Smith Christopher M
SEC CIK 1436707 · EDGAR
Most active insiders at NEO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Aunan Greg D | CAO | — | $321.4K |
| 2 | Olivo Alicia C | EVP, GC, Business Development | — | $300.2K |
| 3 | Stone Warren | Pres, COO | — | $276.6K |
| 4 | TETRAULT LYNN A. | Dir | — | $118.8K |
| 5 | Green Marjorie C | Dir | — | — |
| 6 | Gunn Neil | Dir | — | — |
| 7 | Kelly Michael Aaron | Dir | — | — |
| 8 | Perez David Brian | Dir | — | — |
| 9 | Kenny John P. | Dir | — | — |
| 10 | KANOVSKY STEPHEN M | Dir | — | — |
Smith Christopher M made no open-market trades at NEO in the last 12 months.
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-25 | 2025-02-23 | NEO | NEOGENOMICS INC | Smith Christopher M | CEO | M - OptEx | $0.00 | +57.4K | 655.7K | +10% | $0 |
| D | 2025-02-25 | 2025-02-23 | NEO | NEOGENOMICS INC | Smith Christopher M | CEO | F - Tax | $0.00 | -14.1K | 641.6K | -2% | $0 |
| D | 2025-02-03 | 2025-01-30 | PACB | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Smith Christopher M | Dir | A - Grant | $0.00 | +54.1K | 54.1K | New | $0 |
| DA | 2024-12-04 | 2024-05-11 | NEO | NEOGENOMICS INC | Smith Christopher M | CEO | M - OptEx | $0.00 | +48.1K | 650.3K | +8% | $0 |
| DA | 2024-12-04 | 2024-05-11 | NEO | NEOGENOMICS INC | Smith Christopher M | CEO | F - Tax | $14.86 | -18.9K | 631.4K | -3% | -$281.0K |
| 2024-08-19 | 2024-08-15 | NEO | NEOGENOMICS INC | Smith Christopher M | CEO | F - Tax | $0.00 | -33.1K | 646.3K | -5% | $0 | |
| DM | 2024-05-14 | 2024-05-11 | NEO | NEOGENOMICS INC | Smith Christopher M | CEO | M - OptEx | $0.00 | +96.1K | 650.3K | +17% | $0 |
| D | 2024-05-14 | 2024-05-11 | NEO | NEOGENOMICS INC | Smith Christopher M | CEO | F - Tax | $14.86 | -18.9K | 631.4K | -3% | -$281.0K |
| D | 2023-06-08 | 2023-06-06 | QDEL | QuidelOrtho Corp | Smith Christopher M | Dir | A - Grant | $0.00 | +2,248 | 2,249 | +224,800% | $0 |
| 2023-05-31 | 2023-05-27 | QDEL | QuidelOrtho Corp | Smith Christopher M | Dir | F - Tax | $85.54 | -1,225 | 33.3K | -4% | -$104.8K | |
| DM | 2022-08-17 | 2022-08-15 | NEO | NEOGENOMICS INC | Smith Christopher M | CEO | A - Grant | $0.00 | +602.2K | 336.8K | New | $0 |
| A | 2022-08-01 | 2022-05-27 | QDEL | QuidelOrtho Corp | Smith Christopher M | Dir | A - Grant | — | +34.6K | 34.6K | New | — |
| D | 2022-06-01 | 2022-05-27 | QDEL | QuidelOrtho Corp | Smith Christopher M | Dir | A - Grant | — | +34.6K | 34.6K | New | — |
Purchase Sale Sale after option exercise All abbreviations